Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other ...
The FDA has approved three new pediatric indications for somapacitan-beco, a once-weekly, long-acting growth hormone injection, according to a press release issued by Novo Nordisk.Somapacitan-beco ...